Trial-Level Safety Signals to Know Pancreatitis Both compound classes (GLP-1 agonists and amylin analogs) have a small but documented pancreatitis signal across the GLP-1 trial database
Perfect for Individuals Who: Want brighter, even-toned, and glowing skin
Practical Strategies to Prevent Weight Regain While on GLP-1 Preventing weight gain or regain while using GLP-1 requires three parallel actions: dose escalation as needed, behavioral consistency, and nutritional quality
Signs That Warrant Immediate Evaluation Resting heart rate consistently above 100 bpm, new-onset tremor, unexplained weight loss despite stable appetite, heat intolerance, or anxiety that has worsened since adding ashwagandha
Patients should seek prompt medical guidance for severe or persistent vomiting, signs of dehydration, severe abdominal pain, fainting, symptoms of low blood sugar, inability to keep fluids down, worsening constipation with pain or bloating, or any symptom that feels unsafe
If services are provided on a time-and-materials basis, any shared estimates are for planning purposes only.